Literature DB >> 20201942

Emergent T-helper 2 profile with high interleukin-6 levels correlates with the appearance of bortezomib-induced neuropathic pain.

Silvia Mangiacavalli, Alessandro Corso, Mara De Amici, Marzia Varettoni, Enrico Alfonsi, Alessandro Lozza, Mario Lazzarino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20201942     DOI： 10.1111/j.1365-2141.2010.08138.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  11 in total

1.  Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial.

Authors:  Maximilian Merz; Hans Salwender; Mathias Haenel; Elias K Mai; Uta Bertsch; Christina Kunz; Thomas Hielscher; Igor W Blau; Christof Scheid; Dirk Hose; Anja Seckinger; Anna Jauch; Jens Hillengass; Marc S Raab; Baerbel Schurich; Markus Munder; Peter Brossart; Christian Gerecke; Hans-Walter Lindemann; Matthias Zeis; Katja Weisel; Jan Duerig; Hartmut Goldschmidt
Journal:  Haematologica       Date:  2016-08-18       Impact factor: 9.941

2.  Paeoniflorin Ameliorates BiPN by Reducing IL6 Levels and Regulating PARKIN-Mediated Mitochondrial Autophagy.

Authors:  Runjie Sun; Jiang Liu; Manya Yu; Mengting Xia; Yanyu Zhang; Xiaoqi Sun; Yunsheng Xu; Xing Cui
Journal:  Drug Des Devel Ther       Date:  2022-07-13       Impact factor: 4.319

3.  Unilateral Cervical Polyneuropathies following Concurrent Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer.

Authors:  Alhasan Elghouche; Tom Shokri; Yewen Qin; Susannah Wargo; Deborah Citrin; Carter Van Waes
Journal:  Case Rep Otolaryngol       Date:  2016-02-25

Review 4.  Molecular Biology and Clinical Mitigation of Cancer Treatment-Induced Neuropathy.

Authors:  Gerald M Higa; Corbin Sypult
Journal:  Clin Med Insights Oncol       Date:  2016-04-03

5.  CXCR1/2 pathways in paclitaxel-induced neuropathic pain.

Authors:  Laura Brandolini; Elisabetta Benedetti; Pier Adelchi Ruffini; Roberto Russo; Loredana Cristiano; Andrea Antonosante; Michele d'Angelo; Vanessa Castelli; Antonio Giordano; Marcello Allegretti; Annamaria Cimini
Journal:  Oncotarget       Date:  2017-04-04

6.  T Cells as an Emerging Target for Chronic Pain Therapy.

Authors:  Geoffroy Laumet; Jiacheng Ma; Alfred J Robison; Susmita Kumari; Cobi J Heijnen; Annemieke Kavelaars
Journal:  Front Mol Neurosci       Date:  2019-09-11       Impact factor: 5.639

7.  Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse.

Authors:  Valentina A Carozzi; Cynthia L Renn; Michela Bardini; Grazia Fazio; Alessia Chiorazzi; Cristina Meregalli; Norberto Oggioni; Kathleen Shanks; Marina Quartu; Maria Pina Serra; Barbara Sala; Guido Cavaletti; Susan G Dorsey
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

Review 8.  Chemotherapy-induced peripheral neurotoxicity and complementary and alternative medicines: progress and perspective.

Authors:  Xiao L Cheng; Hong Q Liu; Qi Wang; Jie G Huo; Xiao N Wang; Peng Cao
Journal:  Front Pharmacol       Date:  2015-10-23       Impact factor: 5.810

Review 9.  An Overview of Bortezomib-Induced Neurotoxicity.

Authors:  Cristina Meregalli
Journal:  Toxics       Date:  2015-07-27

10.  Probiotic DSF counteracts chemotherapy induced neuropathic pain.

Authors:  Vanessa Castelli; Paola Palumbo; Michele d'Angelo; Nandha Kumar Moorthy; Andrea Antonosante; Mariano Catanesi; Francesca Lombardi; Dalila Iannotta; Benedetta Cinque; Elisabetta Benedetti; Rodolfo Ippoliti; Maria Grazia Cifone; Annamaria Cimini
Journal:  Oncotarget       Date:  2018-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.